HRA Pharma

HRA Pharma UK is the British subsidiary of the specialty pharmaceutical company focused on women’s health, endocrinology, and oncology supportive care. The company develops and markets emergency contraception including ellaOne (ulipristal acetate), hormone therapies, and treatments for rare endocrine conditions including Cushing’s syndrome.